Bio Blast Pharma (ORPN) in Focus: Stock Moves Up 26.6%

Bio Blast Pharma Ltd. (ORPN) was a big mover last session, as its shares rose roughly 27% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company since Oct 29, as the stock is now down over 3%.

Over the last 30 days, this biopharmaceutical company witnessed one negative estimate revision and the Zacks Consensus Estimate also moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if Wednesday’s jump can turn into more strength down the road.

Bio Blast Pharma currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Other better-ranked med-drugs stocks include Valeant Pharmaceuticals International, Inc. (VRX), Lannett Company, Inc. (LCI) and Sucampo Pharmaceuticals, Inc. (SCMP). All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

BIO BLAST PHARMA LTD ORD (ORPN): Free Stock Analysis Report

VALEANT PHARMACEUTICALS INTERNAT (VRX): Free Stock Analysis Report

LANNETT COMP (LCI): Free Stock Analysis Report

SUCAMPO PHARMACEUTICALS CL A (SCMP): Free Stock Analysis Report

Zacks Investment Research

Source Article from http://finance.yahoo.com/news/bio-blast-pharma-orpn-focus-094402320.html
Bio Blast Pharma (ORPN) in Focus: Stock Moves Up 26.6%
http://finance.yahoo.com/news/bio-blast-pharma-orpn-focus-094402320.html
http://news.search.yahoo.com/news/rss?p=pharma
pharma – Yahoo News Search Results
pharma – Yahoo News Search Results



コメントを残す

メールアドレスが公開されることはありません。 * が付いている欄は必須項目です

次のHTML タグと属性が使えます: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>